Abstract
We present the case of a 20-year-old woman who developed rhabdomyolysis, disseminated intravascular coagulopathy and multi-organ failure induced by ecstasy. Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg.kg -1 dantrolene. Subsequent genetic testing revealed a novel potentially pathogenic variant in the ryanodine receptor type 1 gene. However, caffeine-halothane contracture testing of the patient's mother who carried the same gene variant was negative for malignant hyperthermia. © Anaesthesia © 2012 The Association of Anaesthetists of Great Britain and Ireland.
Cite
CITATION STYLE
Russell, T., Riazi, S., Kraeva, N., Steel, A. C., & Hawryluck, L. A. (2012). Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia, 67(9), 1021–1024. https://doi.org/10.1111/j.1365-2044.2012.07226.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.